What one share of RxSight holds
RxSight, Inc. is a commercial-stage medical technology company dedicated to providing high-quality customized vision to patients following cataract surgery. Our proprietary RxSight® Light Adjustable Lens system (“RxSight system”) is the first and only commercially available premium cataract technology that enables doctors to customize and optimize visual acuity for patients after surgery.
RxSight’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $2.94 |
|---|---|
| Profit | −$1.14 |
| Capex (buildings and equipment) | $0.11 |
| Free cash flow | −$0.66 |
| Cash and investments | $0.32 |
| Book value | $6.33 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2021 | $1.66 | −$3.57 | $0.14 | −$3.42 | — | — |
| 2022 | $1.77 | −$2.41 | $0.09 | −$2.21 | — | $3.18 |
| 2023 | $2.59 | −$1.41 | $0.14 | −$1.35 | — | $4.44 |
| 2024 | $3.60 | −$0.71 | $0.14 | −$0.58 | — | $6.96 |
| 2025 | $3.29 | −$0.95 | $0.09 | −$0.47 | — | $6.68 |
Common questions about RxSight
How much does one share of RxSight earn?
Over the last 12 months, RxSight lost $1.14 for each share on $2.94 of sales.
Does RxSight pay a dividend?
RxSight didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is RxSight’s book value per share?
RxSight’s book value is $6.33 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of RxSight have?
Each share of RxSight has $0.32 of cash and investments, as of June 30, 2026.
What is RxSight’s free cash flow per share?
−$0.66 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has RxSight bought back shares?
RxSight’s share count rose about 200% from 2021 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.